Skip to content
Open access · CC-BY via OpenAlex

Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy

Jing Bi, Li Song, Qinglong Guo, Xi Chen, Yaqi Gong, Hao Wu, Fan Zhang, Jingbin Wang, Guoliang Zhang

mSphere · 2025

Abstract

ABSTRACT Tuberculosis (TB), resulting from Mycobacterium tuberculosis (Mtb), is one of the leading causes of morbidity and mortality in humans worldwide. Host-directed therapy (HDT) is a novel approach for treating TB, particularly those with drug resistance. Urolithin A (UroA) produced through bioconversion of plant-derived ellagic acid by gut microbes has been proven to have multiple beneficial effects in a variety of diseases without showing undesired adverse reactions. However, whether UroA has antimycobacterial effect and the underlying mechanism has not yet been reported. Here, we found that UroA significantly inhibited Mtb growth within both macrophages and mice. Moreover, UroA promoted the activation of autophagy(definition) in Mtb-infected macrophages via the protein kinase B–Forkhead box protein O1 signaling pathway, which contributed to the antimycobacterial effect of UroA. Additionally, UroA suppressed the survival of clinically isoniazid (INH)-resistant Mtb (C2) within macrophages, and the combination of UroA and INH synergistically enhanced host elimination of Mtb H37Rv. Therefore, UroA may be utilized as a potential candidate for HDT and as an adjunctive therapy with first-line anti-TB drugs. IMPORTANCE Host-directed therapy (HDT) is a novel approach for treating tuberculosis (TB), particularly those with drug resistance. Urolithin A (UroA) produced through bioconversion of plant-derived ellagic acid by gut microbes has been proven to have multiple beneficial effects in a variety of diseases without showing undesired adverse reactions. We found that UroA significantly inhibited Mycobacterium tuberculosis (Mtb) growth within macrophages. Moreover, UroA suppressed the survival of clinically isoniazid (INH)-resistant Mtb (C2) within macrophages, and the combination of UroA and INH synergistically enhanced host elimination of Mtb H37Rv. Therefore, UroA may be utilized as a potential candidate for HDT and as an adjunctive therapy with first-line anti-TB drugs.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1128/msphere.00061-25
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Bi, J., Song, L., Guo, Q., Chen, X., Gong, Y., Wu, H., Zhang, F., Wang, J., &amp; Zhang, G. (2025). Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy. <em>mSphere</em>. https://doi.org/10.1128/msphere.00061-25
Vancouver
Bi J, Song L, Guo Q, Chen X, Gong Y, Wu H, et al. Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy. mSphere. 2025. doi:10.1128/msphere.00061-25.
BibTeX
@article{jing2025Effect, title = {Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy}, author = {Jing Bi and Li Song and Qinglong Guo and Xi Chen and Yaqi Gong and Hao Wu and Fan Zhang and Jingbin Wang and Guoliang Zhang}, journal = {mSphere}, year = {2025}, doi = {10.1128/msphere.00061-25}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings